Veteran Owned
Over 30 Years of Experience
Opening Hours
Mon-Fri: 8AM - 5PM

Medicare proposes to limit coverage of Biogen Alzheimer’s drug

The program will only cover Aduhelm, which the FDA controversially approved last June, for patients enrolled in clinical trials.

Generated by Feedzy